Pinchas Cohen Net Worth

Pinchas Cohen biography

Dr. Pinchas Cohen serves as Independent Director of the Company. Dr. Cohen co-founded our Company in 2007 and has served as a member of our board of directors since our conversion to a Delaware corporation in 2009. He served as our President from 2009 until 2013. Since April 2012, Dr. Cohen has served as dean of the Davis School of Gerontology at the University of Southern California. He holds the William and Sylvia Kugel Dean’s Chair in Gerontology and acts as executive director of the Ethel Percy Andrus Gerontology Center. Dr. Cohen was affiliated with the University of California, Los Angeles School of Medicine, where he was a member of the faculty until 2012. At the UCLA Mattel Children’s Hospital Dr. Cohen served as director of endocrine/diabetes research and training (from 1999 until 2012), chief of endocrinology and diabetes (from 2001 until 2012) and as vice chair of research (from 2011 until 2012). Dr. Cohen was also co-director of the UCSD-UCLA Diabetes and Endocrinology Research Center from 2007 until 2012. Dr. Cohen has received several awards for his work in the field of aging and the discovery of mitochondrial-derived peptides, including a National Institute of Aging EUREKA Award, the National Institutes of Health Director’s Transformative Research Award and the Glenn Award for Research in Biological Mechanisms of Aging and the AFAR Wright Award. He serves on the boards of several professional journals and societies, including the American Federation for Aging Research and the Growth Hormone Research Society. Our board of directors believes that Dr. Cohen’s leadership in gerontology research and his experience overseeing numerous research programs related to diseases of aging and mitochondrial biology makes him an important contributor to our board of directors.

What is the salary of Pinchas Cohen?

As the Independent Director of CohBar Inc, the total compensation of Pinchas Cohen at CohBar Inc is $64,125. There are 10 executives at CohBar Inc getting paid more, with Steven Engle having the highest compensation of $2,410,850.

How old is Pinchas Cohen?

Pinchas Cohen is 62, he's been the Independent Director of CohBar Inc since 2017. There are 7 older and 5 younger executives at CohBar Inc. The oldest executive at CohBar Inc is Albion Fitzgerald, 71, who is the Independent Chairman of the Board.

What's Pinchas Cohen's mailing address?

Pinchas's mailing address filed with the SEC is C/O COHBAR, INC., 1455 ADAMS DRIVE, SUITE 2050, MENLO PARK, CA, 94025.

Insiders trading at CohBar Inc

Over the last 7 years, insiders at CohBar Inc have traded over $0 worth of CohBar Inc stock and bought 586,523 units worth $136,480 . The most active insiders traders include Misha Petkevich, Kenneth C Cundy, and Jon Leland Stern. On average, CohBar Inc executives and independent directors trade stock every 22 days with the average trade being worth of $9,727. The most recent stock trade was executed by David Greenwood on 1 November 2021, trading 20,000 units of CWBR stock currently worth $8,600.

What does CohBar Inc do?

cohbar (otcqx: cwbr and tsxv: cob.u) is the leader in the research and development of mitochondria-based therapeutics (mbts), an emerging class of drugs for the treatment of diseases associated with aging. mbts originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. this groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. mbts offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.

CohBar Inc executives and stock owners

CohBar Inc executives and other stock owners filed with the SEC include:

• Steven Engle,
  Chief Executive Officer, Director
• Phyllis Gardner,
  Independent Director
• Dr. Kenneth C. Cundy,
  Chief Scientific Officer
• Jeffrey F. Biunno CPA, M.B.A., CPA, MBA,
  CFO, Treasurer & Sec.
• Kenneth Cundy,
  Chief Scientific Officer
• David Greenwood,
  Independent Director
• Jeffrey Biunno,
  Chief Financial Officer, Treasurer, Secretary
• Jon Stern,
  Director
• Misha Petkevich,
  Independent Director
• Albion Fitzgerald,
  Independent Chairman of the Board
• Pinchas Cohen,
  Independent Director
• Nir Barzilai,
  Independent Director
• Jordyn Tarazi,
  Director of Investor Relations
• Dr. Rohit Loomba,
  Scientific Consultant
• Dr. Changhan David Lee Ph.D.,
  Consultant of Mitochondrial Biology
• Dr. David Andrew Sinclair A.O., Ph.D.,
  Co-Founder, Advisor & Consultant
• Dr. Joseph J. Sarret,
  CEO & Director
• Simon Allen,
  Chief Executive Officer
• Marc E. Goldberg,
  
• Philippe Calais,
  Director
• Joseph J. Sarret,
  Chief Executive Officer
• John Amatruda,
  Director
• Carol Nast,
  Director
• Joanne Yun,
  Director
• Stephanie Tozzo,
  Director